Navigation Links
Salugen Announces the U.S. Launch of GenoTrim - a DNA Customized Nutritional Solution for Weight Management
Date:9/11/2007

GenoTrim to play a role on the nation's obesity crisis by addressing

genetics associated with hunger and excess weight.

SAN DIEGO, Sept. 11 /PRNewswire/ -- Salugen, Inc., a personalized health and wellness company, announced the launch of GenoTrim, a DNA-based nutritional solution for weight management*. Attempts to achieve a healthy weight through both standard weight reduction strategies and numerous "gimmicks" have proven unsuccessful for the 58 million overweight individuals in the U.S. GenoTrim uniquely identifies specific genetic factors affecting hunger, metabolism and body composition that may contribute to the weight challenges of many of these individuals.

"GenoTrim tests for five key genes associated with the hereditary contributors to weight and hunger. From the genetic analysis, the individual is provided a nutrient formulation guided by their genetic profile," stated Lonna J. Williams, COO and SVP of Marketing at Salugen, Inc. Williams goes on to say, "GenoTrim is not a lose-weight-quick or magic pill. By addressing gene mutations inhibiting one's ability to manage weight, it provides a measure of control and help to break through obstacles encountered in previous weight loss efforts. Importantly, healthy eating and exercise are essential to proper weight management."

GenoTrim and its ingredients are supported by numerous published clinical studies including the award winning study Dietary Investigation to Evaluate Treatments (D.I.E.T.), lead by Dr. Ken Blum, Chief Scientific Officer of Salugen and a professor in the Department of Physiology and Pharmacology at Wake Forest University School of Medicine. Compared to most nutritional supplements, GenoTrim ingredient combinations have been proven in published, randomized, double-blinded placebo-controlled studies to result in weight loss. In three published clinical studies, GenoTrim resulted in an average weight loss of 12.8 lbs, 17.15 lbs and 26.96 lbs in as few as 8 weeks. Additionally, GenoTrim resulted in significant reductions in sugar cravings and appetite, as well as improvements in sleep and mood.*

Positive case studies have been received from among the 1500 pilot study participants. Additional prospective studies are ongoing. GenoTrim can be purchased through Salugen's distribution partner DNA Services of America or at http://www.GenoTrim.com .

About GenoTrim

GenoTrim is a DNA-customized nutritional solution for weight management. Based upon an analysis of five important genes effecting weight, GenoTrim ingredients and dosages are genetically-guided to address the underlying genetic factors involved in hormones and metabolism that Harvard Medical Experts suggest influence 70% to 80% of overweight cases. By addressing genetic factors that make individuals prone to weight problems, GenoTrim has demonstrated in studies to help reduce weight, appetite, sugar cravings, snacking, and late-night eating, as well as help support improved sleep, mood, and energy levels which results in sustainable weight loss. For more information on GenoTrim, please visit http://www.genotrim.com.

About Salugen

Salugen, Inc., a leading personalized health and wellness company, engages in the discovery, development and commercialization of patent-protected genetic tests and companion DNA-customized therapeutics worldwide. With over 30 years of research conducted on the genetic causes and pharmacology of many healthcare concerns, Salugen is a pioneer and leader in delivering personalized medicine. Currently, the Company commercializes nutrigenomic technologies where genetic analysis guides the formulation and delivery of nutritional solutions that are customized to the individual. The company has headquarters in San Diego, CA, with its high-complexity CLIA-certified laboratory services in Los Angeles, CA. For additional information about the company, please visit http://www.salugen.com.

* These statements have not been evaluated by the U.S. Food and Drug

Administration. This product is not intended to diagnose, treat, cure or

prevent any disease.


'/>"/>
SOURCE Salugen
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Looking ... team-building and cooking events company, offers one-of-a-kind gifts, ranging from gourmet cooking experiences ... California cuisine, and guests leave inspired with new cooking tips and techniques, thanks ...
(Date:4/26/2017)... ... April 25, 2017 , ... LABS, Inc. (LABS) announced in December ... its extensive test menu: Nucleic Acid Testing (NAT) for ZIKV; and Enzyme Immunoassays (EIAs) ... to offer NAT screening for blood donors under an Investigational New Drug (IND) study ...
(Date:4/26/2017)... ... April 26, 2017 , ... As the call for ... industry stakeholders, the discussion surrounding the topic will continue at WEDI 2017- Driving ... Los Angeles, Calif. Hosted by the Workgroup for Electronic Data Interchange (WEDI), the ...
(Date:4/25/2017)... ... 25, 2017 , ... Franz Inc ., an early ... and market leader for Semantic Graph Database technology, today announced ... most effective system for developing and deploying applications to solve the challenges developers ...
Breaking Biology Technology:
(Date:4/5/2017)... -- The Allen Institute for Cell Science today announces the ... and dynamic digital window into the human cell. The ... of deep learning to create predictive models of cell ... growing suite of powerful tools. The Allen Cell Explorer ... available resources created and shared by the Allen Institute ...
(Date:4/5/2017)... April 4, 2017 KEY FINDINGS ... expand at a CAGR of 25.76% during the forecast ... the primary factor for the growth of the stem ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem cell ... application, and geography. The stem cell market of the ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
Breaking Biology News(10 mins):